The drugmaker said it agreed to pay RAPT Therapeutics shareholders $58 per share, with $1.9 billion upfront investment in cash.
Source link
GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments
Date:
More like thisRelated
Strait of Hormuz closure chokes trade and aid for Afghanistan
KABUL, Afghanistan -- When landlocked Afghanistan and neighboring Pakistan...
Cornyn won't commit to backing Paxton if Trump-endorsed AG wins primary
Sen. John Cornyn (R-Texas) on Sunday would not commit...
Global Markets Gain and Oil Prices Retreat as U.S-Iran Peace Talks Continue
Global bond yields dropped and the U.S. dollar slipped...
Transfer rumors, news: Milan failure puts Pulisic future in doubt
May 25, 2026, 04:34 AM ETChristian Pulisic and Luka...